Login / Signup

Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.

Yuto MatsushitaMakito MiyakeNobutaka NishimuraKoshiro NishimotoHideo FukuharaKeita KobayashiMasafumi OyamaKeiji InoueHideyasu MatsuyamaKiyohide FujimotoHideaki Miyake
Published in: International journal of clinical oncology (2023)
These results suggest that PDD-TURBT prolongs RFS in NMIBC patients, except for those with tumors ≥ 30 mm.
Keyphrases
  • muscle invasive bladder cancer
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • photodynamic therapy
  • cancer therapy
  • drug delivery